NIM
TNYA icon

NEOS Investment Management’s Tenaya Therapeutics TNYA Stock Holding History

NEOS Investment Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-169,127
Closed -$326K – 608
2024
Q3 		$326K Buy
169,127
+13,053
+8% +$36.9K 0.01% 534
2024
Q2 		$484K Sell
156,074
-27,346
-15% -$113K 0.02% 462
2024
Q1 		$959K Buy
183,420
+121,261
+195% +$580K 0.06% 270
2023
Q4 		$201K Buy
+62,159
New +$134K 0.02% 499

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

NEOS Investment Management's TNYA Position: Q4 2024 in Review

NEOS Investment Management sold out of Tenaya Therapeutics (TNYA) in Q4 2024, closing a stake of 169,127 shares — an estimated $326K sold.

NEOS Investment Management first reported a position in TNYA in Q4 2023 and held it in 4 quarters. The position peaked at $959K in Q1 2024. 88 funds tracked by Wall St. Rank hold TNYA as of Q4 2024.

  • NEOS Investment Management reported no remaining Tenaya Therapeutics position as of Q4 2024 after selling out during the quarter.
  • NEOS Investment Management sold 169,127 Tenaya Therapeutics shares in Q4 2024, an estimated $326K.
  • NEOS Investment Management first reported a position in Tenaya Therapeutics in Q4 2023 and held it in 4 quarters.
  • NEOS Investment Management's Tenaya Therapeutics position peaked at $959K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2024.

Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.